Stay updated on MK-3475 and Gemcitabine in NSCLC Clinical Trial

Sign up to get notified when there's something new on the MK-3475 and Gemcitabine in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MK-3475 and Gemcitabine in NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page shows routine updates (e.g., last update date); core study content and enrollment remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T01:25:28.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Core content updated with a government-lapse notice and new version v3.2.0; previous v3.1.0 deletion confirms the upgrade.
    Difference
    5%
    Check dated 2025-10-05T10:24:10.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T03:23:34.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, indicating a new release. The 'Back to Top' link was removed as a minor UI change.
    Difference
    0.3%
    Check dated 2025-09-13T17:44:30.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.3%
    Check dated 2025-09-06T15:26:38.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new content related to specific compounds and drugs, such as pembrolizumab. However, many previous topics and terms related to cancer treatment and pharmacological mechanisms have been removed.
    Difference
    6%
    Check dated 2025-08-30T12:09:01.000Z thumbnail image

Stay in the know with updates to MK-3475 and Gemcitabine in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MK-3475 and Gemcitabine in NSCLC Clinical Trial page.